Revenue
NT$33,388M
YoY
+10.9%
MoM vs last year
-8.6pp
Share growing
69%
YTD YoY
+13.7%
YoY
The same companies this year against last year, computed from summed revenue.
+10.9% Latest Oct 2026
MoM vs last year
This month's MoM minus the same month's MoM last year. Below zero means weaker than usual for the season.
-8.6pp Latest Oct 2026
Share growing
Share of companies with revenue above the same month last year. The largest company can't skew it.
69% Latest Oct 2026
101 growing, 45 declining
Companies
| # | Ticker | Name | Revenue | MoM | YoY | YTD | YoY contribution (pp) |
|---|---|---|---|---|---|---|---|
| 106 | 6431 | KL | NT$41.4M | -23.4% | +53.0% | +20.7% | +0.0 |
| 107 | 6730 | LAGIS | NT$41.2M | -6.0% | -3.3% | +2.4% | -0.0 |
| 108 | 4102 | YUNGZIP | NT$40.1M | +28.3% | +15.3% | +7.4% | +0.0 |
| 109 | 6499 | Medeon | NT$38.0M | -83.6% | +2.7% | +67.2% | +0.0 |
| 110 | 3205 | SLS | NT$37.8M | +5.8% | +125.2% | +47.1% | +0.1 |
| 111 | 6841 | EFAI | NT$36.7M | -0.7% | -1.0% | +15.5% | -0.0 |
| 112 | 6598 | Applied BioCode | NT$35.8M | -53.7% | +8.7% | +64.6% | +0.0 |
| 113 | 3164 | GenMont | NT$35.4M | -22.3% | -4.1% | -1.8% | -0.0 |
| 114 | 6661 | WELGENE | NT$33.9M | -4.5% | +22.2% | +6.5% | +0.0 |
| 115 | 4178 | StemCyte | NT$33.0M | +7.6% | +14.1% | +0.6% | +0.0 |
| 116 | 6955 | BONRAYBIO | NT$32.2M | +7.3% | +30.1% | +19.0% | +0.0 |
| 117 | 4133 | Abnova | NT$31.9M | +30.8% | +19.1% | -2.9% | +0.0 |
| 118 | 6615 | SOFIVA | NT$30.2M | -1.2% | -3.0% | -1.9% | -0.0 |
| 119 | 6767 | Wiltrom | NT$29.7M | +2.6% | +29.1% | +3.3% | +0.0 |
| 120 | 8409 | EBM | NT$29.5M | -6.0% | +184.8% | +2.0% | +0.1 |